Mohammed Al Kanan: Early Identification of VTE Risk in Lung Cancer Patients
Mohammed Al Kanan, Director of Research and Studies at Ministry of Health Saudi Arabia, shared a post on LinkedIn about a recent article by Rong Deng et al. published in Frontiers in Molecular Biosciences, adding:
“Pleased to have contributed as a peer reviewer for a newly published original research article in Frontiers in Molecular Biosciences:
Construction and verification of a nomogram to predict the probability of venous thromboembolism in lung cancer patients.
This study tackles an important challenge in oncology: early identification of lung cancer patients at increased risk of venous thromboembolism (VTE) to support more individualized thromboprophylaxis and clinical decision-making.
Among 676 patients with lung cancer, the investigators developed a lung cancer–specific predictive nomogram incorporating clinically relevant factors such as acute infection, prolonged bed rest, D-dimer, adenocarcinoma, CEA, and COMPASS-CAT score.
What makes the findings particularly interesting is the model’s performance: AUC 0.894, outperforming several conventional VTE risk assessment tools, with favorable discrimination and calibration.
The work represents another step toward moving from generalized risk scores to more disease-specific and individualized prediction models—while prospective validation remains essential before widespread clinical implementation.
Grateful for the opportunity to contribute to the peer-review process and advancement of clinically relevant research.”
Title: Construction and verification of a nomogram to predict the probability of venous thromboembolism in lung cancer patients
Authors: Rong Deng, Jing Wu, Fei Tang, Yan Li, Qin Zhong, Ying Tong, Tingting Ni, Yu Zhang
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 13, 2026, 15:08Anastasia Chatzistamati: Unilateral Adrenal Haemorrhage in Primary Antiphospholipid Syndrome
-
Oct 13, 2026, 15:08Yousma Khan: Hematology Practical Series Day 11 Reticulocyte Count and Its Role in Anemia Diagnosis
-
Oct 13, 2026, 14:56Manal Rayyan: Multidisciplinary Collaboration in Rare Bleeding Disorders – Reflections from Abu Dhabi
-
Oct 13, 2026, 14:54Kalyan Roy: Understanding Blood Transfusion Sets for Safe Clinical Administration
-
Oct 13, 2026, 14:52Chedia Aroua: When Pharmacokinetics Meets Geophysics – Finding Unlikely Connections in Hemophilia Care
-
Oct 13, 2026, 14:47Mehmet Can Uğur: Honored by the Presence and Mentorship of Prof. Dargaud at Our Congress
-
Oct 13, 2026, 14:40Cheryl Loetscher: This Day in Drug Discovery – Wakix and H3 Receptor Inverse Agonism in Narcolepsy
-
Oct 13, 2026, 14:30Thirunavukkarasu Angappan: FVIII vs. FIX Expressive Durability – Key Lessons from GENEr8-1 and HOPE-B Long-Term Data
-
Oct 13, 2026, 14:25Alyaa Al-Mughairy: Highlights from the 8th Omani Society of Hematology Congress